Matsubayashi S, Ikema M, Ninomiya Y, Yamaguchi K, Ikegawa S, Nishimura G
Department of Orthopedic Surgery, Nagasaki Prefectural Center of Medicine and Welfare for Children, Isahaya, Tokyo, Japan.
Mol Syndromol. 2013 Mar;4(3):148-51. doi: 10.1159/000346644. Epub 2013 Jan 30.
Spondylometaphyseal dysplasia Algerian type (SMD-A) is an autosomal dominant disorder that was first reported in an Algerian family by Kozlowski et al. [Pediatr Radiol 1988;18:221-226]. Kozlowski's group reported a sporadic case in a 12-year-old Polish boy. They proposed SMD-A as a distinctive skeletal dysplasia and also suggested that a case of SMD reported by Schmidt et al. [J Pediatr 1963;63:106-112] might have had the same disorder. Afterwards, however, no additional report has emerged to date. In addition, the question whether SMD-A belongs to type II collagenopathy (a group of disorders due to a heterozygous mutation of COL2A1) has been continuously under debate. Here we report a 7-year-old Japanese boy with a heterozygous missense mutation in COL2A1, 2582G>T (Gly861Val), whose phenotype matched that of SMD-A. Our observation supports the hypothesis that SMD-A is a variant of type II collagenopathy.
脊椎干骺端发育不良阿尔及利亚型(SMD-A)是一种常染色体显性疾病,最早由科兹洛夫斯基等人在一个阿尔及利亚家庭中报道[《儿科放射学》1988年;18:221 - 226]。科兹洛夫斯基团队报道了一名12岁波兰男孩的散发病例。他们提出SMD-A是一种独特的骨骼发育不良疾病,还认为施密特等人[《儿科学杂志》1963年;63:106 - 112]报道的一例SMD病例可能患有相同疾病。然而,此后至今没有新的报道出现。此外,SMD-A是否属于II型胶原病(一组因COL2A1杂合突变导致的疾病)的问题一直存在争议。在此,我们报告一名7岁日本男孩,其COL2A1基因存在杂合错义突变2582G>T(甘氨酸861缬氨酸),其表型与SMD-A相符。我们的观察结果支持SMD-A是II型胶原病变体这一假说。